Biology:MEOX2

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens

A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Mesenchyme homeobox 2 (MEOX2) is a protein that in humans is encoded by the MEOX2 gene.[1][2]

Function

This gene encodes a member of a subfamily of non-clustered, diverged, antennapedia-like homeobox-containing transcription factor genes. The encoded protein may play a role in the regulation of vertebrate limb myogenesis. Mutations in the related mouse protein may be associated with craniofacial and/or skeletal abnormalities, in addition to neurovascular dysfunction observed in Alzheimer's disease.[2] MEOX2 has been implicated in the initiation of tumors in glioma.[3] Additionally, MEOX2 influences several critical processes in lung cancer, including cellular proliferation, invasion, metastasis, angiogenesis, and the development of drug resistance.[4][5][6]

Interactions

MEOX2 has been shown to interact with PAX1[7] and PAX3.[7]

References

  1. "Molecular cloning and localization of the human GAX gene to 7p21". Genomics 24 (3): 535–540. December 1994. doi:10.1006/geno.1994.1663. PMID 7713505. 
  2. 2.0 2.1 "Entrez Gene: MEOX2 mesenchyme homeobox 2". https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=4223. 
  3. "MEOX2-mediated regulation of Cathepsin S promotes cell proliferation and motility in glioma". Cell Death & Disease 13 (4). April 2022. doi:10.1038/s41419-022-04845-2. PMID 35436995. 
  4. "Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients". Oncotarget 8 (40): 67056–67081. September 2017. doi:10.18632/oncotarget.17715. PMID 28978016. 
  5. "Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer". European Journal of Cancer 160: 189–205. January 2022. doi:10.1016/j.ejca.2021.10.032. PMID 34844838. 
  6. "SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1". Cancer Gene Therapy 32 (3): 327–342. March 2025. doi:10.1038/s41417-025-00873-0. PMID 39971779. 
  7. 7.0 7.1 "Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors". FEBS Letters 499 (3): 274–278. June 2001. doi:10.1016/S0014-5793(01)02556-X. PMID 11423130. Bibcode2001FEBSL.499..274S. 

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.